Novanta Inc.(NOVT) Stock Research - Grey Stern Research
Loading...

Novanta Inc. (NOVT) Stock Analysis

$149.14 (0.62%)

NOVT Financial Performance


Use the table below to view Novanta Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2024

Metric Value Ranking among Peers
Price $149.14 -
52 Week Low $143.18 -
52 Week High $187.12 -
Market Cap $5.4 Billion 4/10
Gross Margin 45% 6/10
Profit Margin 8% 6/10
EBITDA margin 19% 1/10
Q3 - 2024 Revenue $244.4 Million 6/10
Q3 - 2024 Earnings $19.2 Million 6/10
Q3 - 2024 Free Cash Flow $28.7 Million 6/10
Trailing 4 Quarters Revenue $922.8 Million 6/10
Trailing 4 Quarters Earnings $60.1 Million 6/10
Quarterly Earnings Growth -10% 7/10
Annual Earnings Growth -28% 7/10
Quarterly Revenue Growth 10% 3/10
Annual Revenue Growth 1% 6/10
Cash On Hand $92.7 Million 7/10
Short Term Debt $15.0 Million 6/10
Long Term Debt $498.5 Million 5/10

Novanta Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Novanta Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 89.09 1/10
PS 5.81 2/10
PB 7.22 2/10
PC 57.80 1/10
Liabilities to Equity 0.91 5/10
ROA 0.04 6/10
ROE 0.08 4/10
Current Ratio 2.10 6/10
Quick Ratio 0.14 5/10
Long Term Debt to Equity 0.67 4/10
Debt to Equity 0.69 5/10
Burn Rate 20.60 4/10
Cash to Cap 0.02 9/10
CCR 1.50 3/10
EV to EBITDA 124.30 3/10
EV to Revenue 6.26 2/10

Company Details

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

CEO: Mr. Matthijs Glastra

Website: https://www.novanta.com

Address: 125 Middlesex Tpke Bedford, MASSACHUSETTS

Exchange: NASDAQ Global Select

Industry: Scientific & Technical Instruments

Novanta Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Novanta Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Fortive Corporation FTV $27.0 Billion
Sensata Technologies Holding plc ST $4.2 Billion
Itron, Inc. ITRI $4.7 Billion
Badger Meter, Inc. BMI $6.3 Billion
ESCO Technologies Inc. ESE $3.4 Billion
Vishay Precision Group, Inc. VPG $308.9 Million
Mesa Laboratories, Inc. MLAB $733.7 Million
Vontier Corporation VNT $5.5 Billion
Sono-Tek Corporation SOTK $61.6 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
NOVT Income Statements
Quarter Year Revenue Earnings
Q3 2024 $ 244.4 Million $19.2 Million
Q2 2024 $ 235.9 Million $13.8 Million
Q1 2024 $ 230.9 Million $14.7 Million
Q4 2023 $ 211.6 Million $12.5 Million
Q3 2023 $ 221.5 Million $21.2 Million
Q2 2023 $ 229.5 Million $20.9 Million
Q1 2023 $ 219.1 Million $18.3 Million
Q3 2022 $ 223.0 Million $22.5 Million

View All

NOVT Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2024 $92.7 Million $1.4 Billion $510.2 Million $742.2 Million
Q2 2024 $98.5 Million $1.4 Billion $537.3 Million $702.0 Million
Q1 2024 $93.5 Million $1.4 Billion $570.3 Million $681.7 Million
Q4 2023 $105.1 Million $1.2 Billion $391.7 Million $673.5 Million
Q3 2023 $76.0 Million $1.2 Billion $404.1 Million $644.9 Million
Q2 2023 $91.3 Million $1.2 Billion $462.1 Million $626.0 Million
Q1 2023 $82.7 Million $1.2 Billion $475.8 Million $598.0 Million
Q3 2022 $84.6 Million $1.2 Billion $483.7 Million $542.2 Million

View All

NOVT Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2024 $28.7 Million -$3.6 Million -$5.8 Million
Q2 2024 $35.3 Million -$4.9 Million $4.9 Million
Q1 2024 $18.0 Million -$6.4 Million -$11.5 Million
Q4 2023 $31.3 Million $0 $31.3 Million
Q3 2023 $37.8 Million -$6.8 Million -$15.4 Million
Q2 2023 $22.9 Million -$3.3 Million $8.7 Million
Q1 2023 $6.6 Million -$3.6 Million -$17.4 Million
Q3 2022 $11.5 Million -$3.3 Million -$15.9 Million

View All